Shinjini Dhar

PharmD, RPh, MBAc

ad2z8i@r.postjobfree.com 609-***-****

LinkedIn Lawrence Township, NJ 08648

Summary

Dedicated, motivated, detail-oriented and forward-thinking Postdoctoral Fellow with a robust background in Medical Affairs/ Information, strong scientific acumen in oncology and proven track record in strategic leadership, innovation and cross-functional collaboration across Commercial and Marketing, Clinical, Regulatory and Product Development teams. Expertise in developing and implementing medical strategies, ensuring compliance with regulatory standards. Eager to contribute my professional and technical skills from different therapeutic areas to the pharmaceutical industry. Ready to embark on a challenging and rewarding position where my passion for advancing patient outcomes can be instrumental in achieving your company’s core values and patient needs. EDUCATION

Master of Business Administration Candidate (MBAc) 09/2023 - Present Erivan K. Haub School of Business, Saint Joseph’s University, Philadelphia, PA Expected Graduation: 05/2025 GPA (till Fall 2023) 4.00

Doctor of Pharmacy (PharmD - Summa Cum Laude) 09/2017 - 05/2023 Ernest Mario School of Pharmacy, Rutgers University, New Brunswick, NJ Graduation: 05/2023 GPA 3.67

RELEVANT FELLOWSHIP and INDUSTRY EXPERIENCE

Medical Affairs and Medical Information Post-Doctoral Fellow 07/2023 - 06/2024 Kenvue (previously: Johnson and Johnson McNeil Consumer Healthcare) in conjunction with Saint Joseph’s University - Philadelphia College of Pharmacy (SJU-PCP) - Fort Washington, PA: Dr. Jaroslav Homola (PharmD) Kenvue component:

● Overseeing two primary functional areas, Pain and Allergy with additional involvement in Supplements to aid in new consumer product development through advanced medical information / clinical expertise.

● Spearheading product’s content creations by leveraging scientific expertise and market knowledge to establish and build a robust network of professional relationships and engage with diverse Health Care Providers (HCPs) and Key Opinion leaders

(KOL) as aligned with medical strategy

● Experienced in promotional review committees to ensure medically supported data through commenting, improving, approving, or rejecting material based on established company practice and FDA regulation.

● Developed and executed a research plan to identify novel pain molecular pathways for lead generation.

● Collaborated with Marketing and Product Development Teams to identify key attributes and design inputs from customers and patient insight to gain expertise in drug delivery technologies.

● Presented on “Strengthening Youth Emotional Health” at the annual CDC PROTECT meeting by leveraging research data from the Association of Public Safety Communications Officials (APCO) with continued management and mentorship for the Mental Health Summit to be held in March 2024.

● Orchestrated recruitment initiatives end-to-end by navigating ninety candidates to final two hires.

● Mentored pharmacy students during their Kenvue rotations to help them meet key deliverables for business needs.

● Formulated “Dear HCP letters” on topics relevant to the FDA, standard and custom response letters and monitor and manage escalated queries from the Medical Information Contact Center.

● Analyzed and interpreted clinical study data to provide medical support, training and education to Marketing and Sales.

● Conducted literature searches to substantiate product claims with robust and accurate scientific evidence.

● Improved scientific verbal and writing skills by delivering and authoring high-quality, balanced medical and scientific information response documents regarding specific products and responding to unsolicited research/clinical inquiries, FAQs from internal and external stakeholders promptly.

Page 1 4

SJU-PCP Component:

● Conducting research on Continuing Education (CE) topic regarding Trastuzumab in unresectable or metastatic Non-Small Cell Lung Cancer (NSCLC) with activating ERBB2 mutations furthering my expertise and knowledge in oncology.

● Advising the IPhO Student Chapter as the Liaison through supervision of case competitions.

● Mentoring P2-P4 pharmacy students during their clinical skills classes and small group teaching to help them successfully develop a capstone presentation.

● Formalized a comprehensive Teaching and Learning Portfolio, incorporating a personal Teaching Philosophy, with feedback from my mentor, highlighting my diverse teaching experiences gained throughout the one-year fellowship. Pharmacy Extern - New Product and Business Development 01/2023 - 03/2023 Janssen, Johnson and Johnson Innovative Medicine - Titusville, NJ; Dr. Mary Mettias (PharmD)

● Executed competitive market research, landscape assessments and analysis on late stage assets in Acute Myeloid Leukemia

(AML) and bispecifics for solid tumors.

● Recommended solutions and innovative ideas for the US and Global New Product and Business Development Team.

● Pitched a unified and informed perspective on investment decisions that affect the future US commercial business. KEY RESEARCH EXPERIENCES

Fam-Trastuzumab Deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) for Adult Patients with Unresectable or Metastatic Non-Small Cell Lung Cancer with activating ERBB2 mutations. Shinjini Dhar. Will present in 03/2024 Benzodiazepines Related Falls in geriatric patients. Shinjini Dhar, Kristin Bohnenberger, Mei T. Liu, Janine Smentkowski. Presented at: ASHP Midyear in 12/2022 and Rutgers Pharmacy Research Day in 04/2023 Levonorgestrel-Releasing IUD System and Breast Cancer: A Literature Review. Hyoeun Kim, Carolyn Hart, Shinjini Dhar, Elise Gerdes, Tiffany Lin, Rebecca Liu, Lauren Aleksunes. Presented at: LKS Convention in 07/2020 PROTAC-E3 molecules on T4 metastatic castration resistant prostate cancer. Shinjini Dhar, Issac Kim, Gentauk Lee, CINJ. Presented at: CINJ in 08/2019

RELEVANT CLINICAL ADVANCED PRACTICE PHARMACY EXPERIENCES (APPE) Pharmacy Extern - Critical Care and Internal Medicine 03/2023 - 04/2023 Monmouth Medical Center (MMC), Monmouth, NJ; Dr. Julie Saleh (PharmD, BCPS)

● Attended multidisciplinary rounds in the ICU and gained understanding of disease states like shocks, cardiovascular and renal disorders, and others.

● Developed a systemic and logical approach to monitor patient pharmacotherapy and provided appropriate recommendations. Pharmacy Extern - Ambulatory Care 11/2022 - 12/2022 Indian Health Service - Crownpoint Healthcare Facility, NM; Lt. Adena Yau (PharmD)

● Spearheaded Diabetes, Pain and Family Medicine counseling and vaccine clinics under pharmacist and doctor supervision.

● Documented meaningful interventions, researched drug information questions, Journal clubs and seminars. Pharmacy Extern (KNIGHT Scholar) 05-07/2022 and 09-11/2022 Penn Medicine - Princeton Medical Center (PMC); Princeton, NJ; Dr. Philip Coco (PharmD, BCPS), Dr. Kristin Bohnenberger

(PharmD, DABAT), Dr. Mona Patel (PharmD), Dr. Mei T. Liu (PharmD, BCPP) KNIGHT Scholar: Knowledge Networking Innovation Graduate Health-System Training (longitudinal 4-cycle rotation)

● Internal Medicine: Attended interdisciplinary rounds and answered drug information questions.

● Emergency Medicine: Conducted thorough medication reconciliations and consulted physicians.

● Hospital Administration: Shadowed integral members of pharmacy and understand workflow.

● Psychiatric Medicine: Attended interdisciplinary rounds and provided recommendations with the pharmacy team.

● Topic discussions: Alcohol Withdrawal, ACLS, Major Depressive Disorder, Hyponatremia, RSI, Shock, Stroke, Toxicology.

● Spearheaded a longitudinal research project on Benzodiazepine-related falls in geriatric patients. Page 2 4

OTHER PHARMACY WORK EXPERIENCES

Pharmacy Intern and Technician 05/2020 - 04/2023

Robert Wood Johnson University Hospital, Hamilton, NJ; Dr. Jonathan Margolin (PharmD, RPh) Pharmacy Intern and Technician 01/2018 - 04/2020

CVS Health, Lawrenceville, NJ; Dr. Valerie Franceschini (PharmD, RPh) PRESENTATIONS

Journal Clubs:

Adagrasib in Non-Small Cell Lung Cancer harboring a KRAS G12C mutation. Presented to: MMC Pharmacists and students in 03/2023 Efficacy and safety of the glucagon-like peptide 1 analog oral semaglutide and the sodium–glucose cotransporter 2 inhibitor empagliflozin were compared in patients with type 2 diabetes uncontrolled on metformin. Presented to: IHS Crownpoint Pharmacy Staff and Nursing Staff in 11/2022 Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia Presented to: PMC Pharmacists and students in 10/2022 Continuation of outpatient buprenorphine therapy after dispensing suboxone from ED Presented to: PMC Pharmacists and students in 06/2022 Apixaban and Rivaroxaban use for Atrial Fibrillation in patients with obesity Presented to: PMC Pharmacists and students in 05/2022 Landscape Analyses:

AML Market Research on late stage assets Presented to: Janssen US and Global NP&BD in 03/2023 Bispecifics in solid tumors Presented to: Janssen US and Global NP&BD in 03/2023 Monographs:

Auvelity (Axsome Therapeutics Inc.) Presented to: PMC Pharmacists and students in 10/2022 Lucemyra (US WorldMeds Inc.) Presented to: PMC Pharmacists and students in 10/2022 Spravato (Janssen Pharmaceuticals) Presented to: PMC Pharmacists and students in 10/2022 Patient Case Presentations:

Hyperosmolar Hyperglycemic State Presented to: MMC Pharmacists and students in 04/2023 Oxcarbazepine induced Hyponatremia Presented to: PMC Pharmacists and students in 10/2022 Systemic Lupus Erythematosus Presented to: PMC Pharmacists and students in 07/2022 Seminars:

Smoking cessation Presented to: IHS Crownpoint Pharmacists and students in 12/2022 Autism Spectrum Disorder and the role of oxytocin Presented to: PMC Pharmacists and students in 10/2022 Status Epilepticus Presented to: PMC Pharmacists and students in 07/2022 Other presentations:

Strengthening Youth Emotional Health and Preventing Suicide Contagion on Social Media Kenvue Research Project Presented to: CDC PROTECT and stakeholders in 11/2023 Multivitamin/ Mineral/ Supplement Formulary Project Formulary Evaluation Project Presented to: IHS Pharmacists and students in 12/2022 Page 3 4

Word on the Street: “What you need to know about New and Emerging street drugs” Service Project Presented to: EMS personnel for CE credits in 07/2022 Levetiracetam and Buprenorphine Publications

Drug of the month article in the PMC ED Newsletter Presented to: PMC Pharmacists and ED staff 07/2022 Apixaban Patient Counseling

Outpatient Clinic Counseling Presented to: PMC Pharmacist and patients in 05/2022 CORE COMPETENCIES AND SKILLS

● Strong Scientific Background

● Strong Oncology Therapeutic Area

curiosity and expertise

● Project Management and Coordination

● Team and Crossfunctional Collaboration

● Multitasking and Time Management

● Critical Thinking and Problem Solving

● Verbal and Written Communication/

Presentation Skills

● Adaptability

● Interpersonal Skills

● Technologically Adept and Proficient

● Dynamic Leadership Skills

PROFESSIONAL LEADERSHIP and ORGANIZATIONAL EXPERIENCES

● Student National Pharmaceutical Operation E-Board Member 09/2019 - 05/2022

● Pharmacy Governing Council (PGC) Mentor 09/2018 - 05/2022

● Lambda Kappa Sigma (LKS) New Member Educator 05/2018 - 05/2020

● New Jersey Society of Health-System Pharmacists Fundraising Chair 09/2019 - 12/2020 COMMUNITY and SERVICE EXPERIENCES

`

● Rutgers COVID Vaccine clinics 05/2022-12/2022

● Rutgers Dance Marathon 04/2020

● Rutgers Service Day 09/2018-12/2019

LICENSES and CERTIFICATIONS

● Pharmacist License 09/2023 - 08/2025

● AHA CPR and AED certified 03/2021-present

● APha Immunization certified 02/2021-present

● APhA Blood glucose and Blood pressure screening certified 10/2019 - present Page 4 4

Contact this candidate